NIGMS National and Regional Resources - DNASU

NIGMS 国家和地区资源 - DNASU

基本信息

  • 批准号:
    10025623
  • 负责人:
  • 金额:
    $ 124.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-15 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY DNASU is a 11 year old non-profit, academic-based repository that provides academia, industry and the government with a wide variety of plasmids including specialized vectors, regulatory genetic sequences, and genes from 1,269 organisms, with many complete genome collections, including the first complete human set. Users access the repository through our website, https://dnasu.org/, where they can: view pertinent clone, gene and vector information; order clones; and utilize link-outs to reach external resources such as protocols and publications. DNASU acquires plasmids both through in-house production by our high throughput cloning pipeline and through deposition by outside research groups. In addition, we partnered with the Protein Structure Initiative (PSI), for whom we performed full-length sequence verification and annotation on plasmids from multiple PSI centers before distributing them. Distribution is initiated when a user visits DNASU to request selected construct(s). Technicians subculture and ship the glycerol stocks for a nominal re-charge fee. DNASU maintains and archives over 260,000 unique plasmids. The DNASU website sees an average of 3,000 unique visitors per month, receives 5,000 orders and distributes over 35,000 plasmids per year to scientists worldwide. DNASU received funding from NIGMS through the PSI initiative that enabled the addition of >93,000 plasmids to its collection and the development of software tools for locating and using clones, thus creating a unique worldwide resource. We also received funds from NIGMS Legacy program to improve the infrastructure, member collection, visibility and sustainability of the repository. We have made significant inroads to create a self-sustaining effort whereby we can continue to distribute clones from our existing collection. However, the number of clones we distribute, although large, is small relative to the massive size of the collection we must maintain, so our sales do not support continued database/computer programming, upkeep and updating of our collection, or acquisition of new collections. We recognize that the scientific community needs a comprehensive archival site like ours in order to continue expanding scientific knowledge on the many proteins that have not yet been studied. We are seeking funding to support our operations and customer support to: 1) Maintain and Improve the Physical Plasmid Repository by refining wet lab methods, updating targeted collections to current expression vectors, refreshing clones to ensure viability, and assisting with acquisition of orphaned collections; 2) Enhance Bioinformatics Capabilities of DNASU to stay current with modern hardware, software and operating systems, and to enhance the DNASU database and bioinformatics pipelines for sequence annotation of the physical clones and the related biological information; and 3) Improve Customer Experience and Outreach by re-constructing the DNASU interface for order placement, improving technical support, and engaging scientists through social media support.
项目概要 DNASU 是一个已有 11 年历史的非营利性学术存储库,为学术界、工业界和 政府拥有多种质粒,包括专用载体、调控基因序列和 来自 1,269 个生物体的基因,拥有许多完整的基因组集合,包括第一个完整的人类基因组。 用户通过我们的网站 https://dnasu.org/ 访问存储库,他们可以:查看相关克隆, 基因和载体信息;订购克隆;并利用链接输出来访问协议等外部资源 和出版物。 DNASU 通过我们的高通量克隆通过内部生产获得质粒 管道并通过外部研究小组的沉积。此外,我们还与 Protein Structure Initiative (PSI),我们为他们进行了质粒全长序列验证和注释 在分发之前从多个 PSI 中心获取。当用户访问 DNASU 请求时启动分发 选定的构建体。技术人员以象征性的充值费进行继代培养和运输甘油库存。 DNASU 维护并存档超过 260,000 个独特的质粒。 DNASU 网站平均有 3,000 个独特的 每月接待访客 5,000 个订单,每年向世界各地的科学家分发超过 35,000 个质粒。 DNASU 通过 PSI 计划获得了 NIGMS 的资助,增加了超过 93,000 名 收集质粒并开发用于定位和使用克隆的软件工具,从而创建 独特的全球资源。我们还收到了 NIGMS Legacy 计划的资金,以改善 存储库的基础设施、成员集合、可见性和可持续性。我们已经做出了重大的 努力创造一种自我维持的努力,使我们能够继续从现有的产品中分发克隆 收藏。然而,我们分发的克隆数量虽然很大,但相对于 我们必须维护的集合,因此我们的销售不支持持续的数据库/计算机编程, 维护和更新我们的藏品,或收购新的藏品。我们认识到科学 社区需要像我们这样的综合档案网站,以便继续扩展科学知识 许多尚未被研究的蛋白质。我们正在寻求资金来支持我们的运营和 客户支持:1) 通过改进湿实验室维护和改进物理质粒存储库 方法,将目标集合更新为当前表达载体,刷新克隆以确保活力,以及 协助收购孤儿藏品; 2) 增强 DNASU 的生物信息学能力 配备最新的现代硬件、软件和操作系统,并增强 DNASU 数据库和 用于物理克隆和相关生物信息的序列注释的生物信息学管道; 3) 通过重新构建 DNASU 订单界面来改善客户体验和外展 安置、改善技术支持以及通过社交媒体支持吸引科学家。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSHUA LABAER其他文献

JOSHUA LABAER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSHUA LABAER', 18)}}的其他基金

Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck
多重溶液内蛋白质芯片 (MISPA) 用于对病原体引起的头颈部进行高通量、定量、早期分析
  • 批准号:
    10713928
  • 财政年份:
    2023
  • 资助金额:
    $ 124.57万
  • 项目类别:
High-throughput immunoproteomics for cancer biomarker discovery
用于癌症生物标志物发现的高通量免疫蛋白质组学
  • 批准号:
    10688269
  • 财政年份:
    2022
  • 资助金额:
    $ 124.57万
  • 项目类别:
High-throughput immunoproteomics for cancer biomarker discovery
用于癌症生物标志物发现的高通量免疫蛋白质组学
  • 批准号:
    10487345
  • 财政年份:
    2022
  • 资助金额:
    $ 124.57万
  • 项目类别:
NIGMS National and Regional Resources - DNASU
NIGMS 国家和地区资源 - DNASU
  • 批准号:
    10238934
  • 财政年份:
    2020
  • 资助金额:
    $ 124.57万
  • 项目类别:
Rapid Low-Cost Paper-based Biodosimetry that reveals individual organ injuries
快速低成本纸基生物剂量测定可揭示个体器官损伤
  • 批准号:
    10349434
  • 财政年份:
    2020
  • 资助金额:
    $ 124.57万
  • 项目类别:
NIGMS National and Regional Resources - DNASU
NIGMS 国家和地区资源 - DNASU
  • 批准号:
    10400460
  • 财政年份:
    2020
  • 资助金额:
    $ 124.57万
  • 项目类别:
NIGMS National and Regional Resources - DNASU
NIGMS 国家和地区资源 - DNASU
  • 批准号:
    10454321
  • 财政年份:
    2020
  • 资助金额:
    $ 124.57万
  • 项目类别:
Rapid Low-Cost Paper-based Biodosimetry that reveals individual organ injuries
快速低成本纸基生物剂量测定可揭示个体器官损伤
  • 批准号:
    10571697
  • 财政年份:
    2020
  • 资助金额:
    $ 124.57万
  • 项目类别:
Rapid Low-Cost Paper-based Biodosimetry that reveals individual organ injuries
快速低成本纸基生物剂量测定可揭示个体器官损伤
  • 批准号:
    10092103
  • 财政年份:
    2020
  • 资助金额:
    $ 124.57万
  • 项目类别:
NIGMS National and Regional Resources - DNASU
NIGMS 国家和地区资源 - DNASU
  • 批准号:
    10797096
  • 财政年份:
    2020
  • 资助金额:
    $ 124.57万
  • 项目类别:

相似海外基金

Mechanisms of mutant p53 reactivation
突变体 p53 重新激活的机制
  • 批准号:
    10719196
  • 财政年份:
    2023
  • 资助金额:
    $ 124.57万
  • 项目类别:
2023 Atherosclerosis
2023 动脉粥样硬化
  • 批准号:
    10675221
  • 财政年份:
    2023
  • 资助金额:
    $ 124.57万
  • 项目类别:
Development and Production of Standardized Reference Diets for Zebrafish Research
斑马鱼研究标准化参考饲料的开发和生产
  • 批准号:
    10823702
  • 财政年份:
    2023
  • 资助金额:
    $ 124.57万
  • 项目类别:
Mentoring in cholinergic regulation of vascular oxidation
血管氧化的胆碱能调节的指导
  • 批准号:
    10664768
  • 财政年份:
    2023
  • 资助金额:
    $ 124.57万
  • 项目类别:
Targeting microglial cell iron-handling in Alzheimer’s Disease
靶向阿尔茨海默病中的小胶质细胞铁处理
  • 批准号:
    10603992
  • 财政年份:
    2023
  • 资助金额:
    $ 124.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了